101 related articles for article (PubMed ID: 5632211)
1. [The thyroid activator with prolonged action, L.A.T.S., and the mechanism of hyperthyroidism].
Savoie JC
Rev Fr Etud Clin Biol; 1967 Dec; 12(10):941-5. PubMed ID: 5632211
[No Abstract] [Full Text] [Related]
2. [Etiology of Basedow's disease, with special reference to LATS].
Nagata K
Naika Hokan; 1969 Jul; 16(7):297-317. PubMed ID: 4901097
[No Abstract] [Full Text] [Related]
3. Thyroid stimulating substances in human saliva.
Sahadevan V; Field EO
Strahlentherapie Sonderb; 1968; 67():425-35. PubMed ID: 4180681
[No Abstract] [Full Text] [Related]
4. The long-acting thyroid stimulator.
Munro DS
J R Coll Physicians Lond; 1972 Apr; 6(3):309-15. PubMed ID: 5066947
[No Abstract] [Full Text] [Related]
5. [New ideas on the regulation of thyroid function by LATS (long-acting thyroid stimulator) and their repercussion on human pathology].
Strumia E
Minerva Med; 1967 Nov; 58(90):3879-85. PubMed ID: 5630606
[No Abstract] [Full Text] [Related]
6. [Long-acting thyroid stimulator].
Titov VN
Klin Med (Mosk); 1969 Oct; 47(10):31-9. PubMed ID: 4915396
[No Abstract] [Full Text] [Related]
7. [Characterization of the long-acting thyroid stimulator. Considerations on preliminary results].
Tourneur R; Letonturier P; Sénécal P
MMW Munch Med Wochenschr; 1974 Mar; 116(13):677-9. PubMed ID: 4212576
[No Abstract] [Full Text] [Related]
8. [Exophthalmic goiter and long acting thyroid stimulator].
Ochi Y; Yatsutani T; Abe S; Shiomi K
Horumon To Rinsho; 1970 Nov; 18(11):907-14. PubMed ID: 5536677
[No Abstract] [Full Text] [Related]
9. LATS and Graves' disease.
Soloman DH; Chopra IJ
Calif Med; 1970 Aug; 113(2):50-5. PubMed ID: 5538194
[No Abstract] [Full Text] [Related]
10. Current concepts concerning the pathogenesis of the hyperthyroidism of Graves' disease.
Orth DN
J Tenn Med Assoc; 1967 Jan; 60(1):41-7. PubMed ID: 5343003
[No Abstract] [Full Text] [Related]
11. [Long-acting thyroid stimulator (L.A.T.S.) and its place in the physiopathogeny of Basedowian hyperthyroidism].
Guéritée N
Rev Fr Endocrinol Clin; 1968; 9(4):351-66. PubMed ID: 5755332
[No Abstract] [Full Text] [Related]
12. Evolution of the concept of the pathogenesis of toxic diffuse goitre (Graves' disease) and an assessment of the long-acting thyroid stimulator (L.A.T.S.).
Hassan HA
J Egypt Med Assoc; 1978; 61(1-2):111-20. PubMed ID: 583050
[No Abstract] [Full Text] [Related]
13. Long-acting thyroid stimulator: A review.
Joasoo A
Med J Aust; 1970 Mar; 1(12):595-8. PubMed ID: 4910668
[No Abstract] [Full Text] [Related]
14. [The long-acting thyroid stimulator (LATS)].
Masala C
Folia Allergol (Roma); 1969; 16(3):249-63. PubMed ID: 4931876
[No Abstract] [Full Text] [Related]
15. [Serum thyrotropic hormone (T.S.H.) and the long acting stimulator substance (L.A.T.S.) in hyperthyroidism. Preliminary communication].
Bonnyns M
Rev Fr Etud Clin Biol; 1967 Jan; 12(1):77-9. PubMed ID: 6052803
[No Abstract] [Full Text] [Related]
16. [Long acting thyroid stimulating immunoglobulin in pathogenesis of diffused thyrotoxicosis (author's transl)].
Zao WS; Wang SZ
Sheng Li Ke Xue Jin Zhan; 1981 Feb; 12(2):119-25. PubMed ID: 6895561
[No Abstract] [Full Text] [Related]
17. [Research of long-acting thyreotropic plasma factor (L.A.T.S.) (personal experience based on 224 cases of hyperthyroidism)].
Tourniaire J; Mornex R; Durand H
Lyon Med; 1969 Jun; 221(22):1313-9. PubMed ID: 5361955
[No Abstract] [Full Text] [Related]
18. The clinical significance of plasma thyroid-stimulating ctivity in hyperthyroidism.
Hoffmann MJ; Hetzel BS
Australas Ann Med; 1966 Aug; 15(3):204-9. PubMed ID: 4169740
[No Abstract] [Full Text] [Related]
19. The clinical significance of plasma thyroid-stimulating activity in hyperthyroidism.
Hoffmann MJ; Hetzel BS
Australas Ann Med; 1966 Aug; 15(3):204-9. PubMed ID: 4168752
[No Abstract] [Full Text] [Related]
20. Neonatal hyperthyroidism and long-acting thyroid stimulator protector.
Nutt J; Clark F; Welch RG; Hall R
Br Med J; 1974 Dec; 4(5946):695-6. PubMed ID: 4479947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
